BioWorld

Oct. 25, 2001

View Archived Issues

Other News To Note

Read More

Xenon Adds Discovery Capability Through QuantaNova Purchase

Read More

OSI Starts Two More Phase III Trials Of Growth-Factor Drug

Read More

Abbott Buying Vysis In $355M Cash Deal, A 33 Percent Premium

Read More

Affymetrix, Millennium Enter GeneChip Development Deal

Read More

Drugs To Bust Bacterial Biofilm, Cesspit of Antibiotic Resistance, Rampant Infection, Sought Now

Read More